STOCK Sirt3tm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:06779 |
Citation information | RRID:IMSR_EM:06779 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | STOCK Sirt3tm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0496_2_F10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Sirt3tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Sirt3 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0496_2_F10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac males |
Breeding at archiving centre | Chimeras were mated to C57BL/6NTac and maintained on this genetic background. Due to the use of the C57BL/6N-Atm1Brd/a ES cells, agouti and non-agouti offspring may be generated. |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased circulating LDL cholesterol level / MGI
- increased circulating triglyceride level / MGI
- hyperglycemia / MGI
- liver inflammation / MGI
- increased circulating insulin level / MGI
- abnormal lipid homeostasis / MGI
- no abnormal phenotype detected / MGI
- hepatic steatosis / MGI
- no phenotypic analysis / MGI
- liver fibrosis / MGI
- increased circulating VLDL cholesterol level / MGI
- increased circulating cholesterol level / MGI
- decreased oxygen consumption / MGI
- abnormal enzyme/coenzyme level / MGI
- insulin resistance / MGI
- abnormal cell physiology / MGI
- increased susceptibility to diet-induced obesity / MGI
- increased systemic arterial systolic blood pressure / MGI
- increased circulating tumor necrosis factor level / MGI
- increased circulating interferon-gamma level / MGI
- increased circulating interleukin-10 level / MGI
- increased circulating interleukin-6 level / MGI
- increased circulating interleukin-12 level / MGI
- abnormal cytokine level / MGI
- decreased carbon dioxide production / MGI
- increased liver triglyceride level / MGI
- increased total body fat amount / MGI
- increased liver cholesterol level / MGI
- mortality/aging / MGI
- abnormal cellular respiration / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).